Open Innovation Newsletter: Opportunities for startups to work with GSK, Ashdod Port, and JVP!

Open Innovation Newsletter: Opportunities for startups to work with GSK, Ashdod Port, and JVP!


No alt text provided for this image

Startup City Haifa - Digital Health Accelerator is focused on rapidly transforming your startup into the next big thing in digital health.

?We seek innovative post-seed stage, software-oriented, deep-tech startups with fundamental AI and cloud-based solutions, and medical device companies with a strong software element.

?The 8 chosen startups will have the opportunity to collaborate with leaders in the industry, offering the opportunity to have direct access to global markets and investment:?JVP, Margalit Startup City, Road2, NVIDIA, Israel Innovation Authority, Philips, IBM, UBank, Asensus Surgical, Clalit Innovation, SuperPharm, AWS, Rambam Hospital, EY, Bnai Zion Hospital, Reinhold Cohn, SF&Co.

?More information and questions: [email protected].

Apply Here!

No alt text provided for this image

Ashdod Port is excited to announce a new partnership with 500 Global to launch the Ashdod Port Accelerator by 500 Global for founders in Israel!

?The 12-week Accelerator and Proof-of-Concept will select up to 14 startups with solutions in energy, seaport operations, logistics, and shipping.

?Be part of Ashdod’s bustling maritime tech hub, apply by February 3, 2022 to be considered.

Apply Here!

No alt text provided for this image

The GSK Vaccines Hack Days!?

The chosen company will have the opportunity to conduct a Proof of Concept (PoC) and launch a pilot!?

?During this 2-days event, you will spend two days working with your team and supported by GSK field experts. Your goal is to develop a prototype solution to a healthcare-given challenge and showcase it.?

?The challenge is launched by the Disruptive Innovation team at GSK.

There are two different strategies for long RNA sequence assembly from shorter oligos. We are looking for cutting-edge technologies to develop algorithms that based on (1) a given long RNA sequence and (2) a set of constraints will help further our understanding and support decision-making of which strategies are preferred.

Join here!


要查看或添加评论,请登录

Spyre Group - Innovation Ecosystem Design的更多文章